In this Japan-focused role, you will partner closely with local, regional, and global colleagues across Asia Translational Medicine, Oncology Translational Medicine, Translational Research, Clinical Development, and Regulatory to design and deliver strategic, competitive, and scientifically robust clinical biomarker and diagnostic approaches aligned with global development strategies. You will bring deep expertise in clinical biomarkers and diagnostics to inform target engagement, mechanism of action, and patient selection, while incorporating Asia- and Japan-specific scientific, regulatory, reimbursement, and innovation landscape considerations.
You will lead the prioritization and execution of high-impact biomarker and diagnostic strategies in Japan - working closely across Asian regions and in collaboration with external laboratories and partners - to generate high-quality data and plan that enable clinical, regulatory and payor decision-making and support GSK’s global oncology portfolio across the product lifecycle.